Aldagen, Inc. · Durham, NC United States ·(NASDAQ (GM): ALDH)
Company Description
View Aldagen, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Aldagen's work stems from the need for tissue repair. The biopharmaceutical company develops cell regeneration therapies using adult stem cells. It uses a proprietary technology that isolates an enzyme known as aldehyde dehydrogenase, or ALDH, which it believes can target a number of diseases. Aldagen hopes its products will be used to treat hereditary metabolic diseases in children, leukemia, and cardiovascular diseases; all its drugs are in the development stage. The company does its own manufacturing and plans to do its own marketing. Venture capital firm Intersouth Partners holds about 42% of Aldagen, which filed an IPO in late 2009. The company is led by CEO W. Thomas Amick. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Aldagen, Inc. Financials
| Company Type | Private - NASDAQ (GM): ALDH Single Location |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $0.2 |
| 2008 Employees | 24 |
Aldagen, Inc. Executives
11 executives listed for Aldagen, Inc.'s Durham, NC location.
| Title | Name & Bio | Contact |
| Chairman and CEO | W. Thomas Amick | Network |
| President and COO | Edward Field | Network |
| CFO | David Carberry | Network |
Competition
Competitive Landscape for Aldagen, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Aldagen, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!